The Valley Desk

NCT05126277 · Interventional trial

Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

Overall registry status Active not recruiting

Phase 3

Conditions Lupus Nephritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov